However, Kim et al. (2017) reported that injection of ATF3 siRNA into zucker diabetic fatty rats induced fatty acid oxidation, inhibited inflammatory responses, and improved glucose tolerance, and thus they proposed that ATF3 could be a target molecule linking hepatic steatosis to impaired glucose homeostasis. Here, ATF3 is linked to fatty liver disease.